Painter Mark M, Johnston Timothy S, Lundgreen Kendall A, Santos Jefferson J S, Qin Juliana S, Goel Rishi R, Apostolidis Sokratis A, Mathew Divij, Fulmer Bria, Williams Justine C, McKeague Michelle L, Pattekar Ajinkya, Goode Ahmad, Nasta Sean, Baxter Amy E, Giles Josephine R, Skelly Ashwin N, Felley Laura E, McLaughlin Maura, Weaver Joellen, Kuthuru Oliva, Dougherty Jeanette, Adamski Sharon, Long Sherea, Kee Macy, Clendenin Cynthia, da Silva Antunes Ricardo, Grifoni Alba, Weiskopf Daniela, Sette Alessandro, Huang Alexander C, Rader Daniel J, Hensley Scott E, Bates Paul, Greenplate Allison R, Wherry E John
Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
Nat Immunol. 2023 Oct;24(10):1711-1724. doi: 10.1038/s41590-023-01613-y. Epub 2023 Sep 21.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of vaccinated individuals is increasingly common but rarely results in severe disease, likely due to the enhanced potency and accelerated kinetics of memory immune responses. However, there have been few opportunities to rigorously study early recall responses during human viral infection. To better understand human immune memory and identify potential mediators of lasting vaccine efficacy, we used high-dimensional flow cytometry and SARS-CoV-2 antigen probes to examine immune responses in longitudinal samples from vaccinated individuals infected during the Omicron wave. These studies revealed heightened spike-specific responses during infection of vaccinated compared to unvaccinated individuals. Spike-specific cluster of differentiation (CD)4 T cells and plasmablasts expanded and CD8 T cells were robustly activated during the first week. In contrast, memory B cell activation, neutralizing antibody production and primary responses to nonspike antigens occurred during the second week. Collectively, these data demonstrate the functionality of vaccine-primed immune memory and highlight memory T cells as rapid responders during SARS-CoV-2 infection.
接种疫苗个体感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的情况日益常见,但很少导致严重疾病,这可能是由于记忆免疫反应的效力增强和动力学加快。然而,在人类病毒感染期间,几乎没有机会严格研究早期回忆反应。为了更好地理解人类免疫记忆并确定持久疫苗效力的潜在介质,我们使用高维流式细胞术和SARS-CoV-2抗原探针来检测在奥密克戎毒株流行期间感染的接种疫苗个体的纵向样本中的免疫反应。这些研究表明,与未接种疫苗的个体相比,接种疫苗个体在感染期间针对刺突蛋白的反应增强。在第一周,针对刺突蛋白的分化簇(CD)4 T细胞和浆母细胞扩增,CD8 T细胞被强烈激活。相比之下,记忆B细胞激活、中和抗体产生以及对非刺突抗原的初次反应在第二周出现。总体而言,这些数据证明了疫苗引发的免疫记忆的功能,并突出了记忆T细胞在SARS-CoV-2感染期间作为快速反应者的作用。